Aspirin (low-dose)
Current understanding
Low-dose aspirin (75-100mg) reduces thrombotic events in PV and ET. Standard prophylactic therapy.
Evidence log
- 2026-03-20 — AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms: cross-connection with doac-primary-prevention-mpn: AVAJAK directly pits DOACs (apixaban/rivaroxaban) against low-dose aspirin as primary thromboprophylaxis in JAK2V617F-positive MPN, formally linking these two prevention strategies in a randomized comparison. (novelty: 4)
Open questions
Related
Contributing findings
Case Report: Polycythemia vera presenting as persistent unexplained low-grade fever.
24-jul-2026
novelty 2
per-area 1
mentions